Isodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinib

被引：3
|
作者：
Loglisci, Giuseppina [1 ]
Breccia, Massimo [1 ]
Nanni, Mauro [1 ]
Mancini, Marco [1 ]
De Cuia, Rosa [1 ]
Cannella, Laura [1 ]
Salaroli, Adriano [1 ]
Federico, Vincenzo [1 ]
Serrao, Alessandra [1 ]
Loglisci, Maria Giovanna [1 ]
Santopietro, Michelina [1 ]
Alimena, Giuliana [1 ]
机构：
[1] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Rome, Italy
来源：
LEUKEMIA & LYMPHOMA | 2011年 / 52卷 / 07期
关键词：
BCR-ABL; GENE AMPLIFICATION; EXPRESSION; MESYLATE; THERAPY; ST1571; CELLS;
D O I：
10.3109/10428194.2011.565394
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1372 / 1375
页数：4
相关论文
共 50 条
  • [31] Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy
    Khorashad, J. S.
    Tantravahi, S. K.
    Yan, D.
    Mason, C. C.
    Qiao, Y.
    Eiring, A. M.
    Gligorich, K.
    Hein, T.
    Pomicter, A. D.
    Reid, A. G.
    Kelley, T. W.
    Marth, G. T.
    O'Hare, T.
    Deininger, M. W.
    LEUKEMIA, 2016, 30 (11) : 2275 - 2279
  • [32] The roles of macromolecules in imatinib resistance of chronic myeloid leukemia cells by Fourier transform infrared spectroscopy
    Baran, Yusuf
    Ceylan, Cagatay
    Camgoz, Aylin
    BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (03) : 221 - 227
  • [33] Response to Dasatinib in a Patient with Concomitant Chronic Myeloid Leukemia and Chronic Lymphocytic Leukemia
    Serpa, Mariana
    Bendit, Israel
    Seguro, Fernanda
    Xavier, Flavia
    Cavalcante, Marcela
    Steinbaum, Daniel
    Nardinelli, Luciana
    Aldred, Vera Lucia
    de Paula, Henrique Moura
    Dorlhiac-Llacer, Pedro Enrique
    ACTA HAEMATOLOGICA, 2010, 124 (02) : 105 - 109
  • [34] Dynamics of Chronic Myeloid Leukemia Under Imatinib Treatment: A Study of Resistance Development
    Badralexi, Irina
    Bordei, Ana-Maria
    Halanay, Andrei
    Radulescu, Ileana Rodica
    MATHEMATICS, 2024, 12 (24)
  • [35] Epigenetic Therapy With Hydralazine and Magnesium Valproate Reverses Imatinib Resistance in Patients With Chronic Myeloid Leukemia
    Cervera, Eduardo
    Candelaria, Myrna
    Lopez-Navarro, Omar
    Labardini, Juan
    Gonzalez-Fierro, Aurora
    Taja-Chayeb, Lucia
    Cortes, Jorge
    Gordillo-Bastidas, Daniela
    Duenas-Gonzalez, Alfonso
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (03) : 207 - 212
  • [36] Apoptosis-Related Gene Expression Profile in Chronic Myeloid Leukemia Patients after Imatinib Mesylate and Dasatinib Therapy
    Ferreira, Aline Fernanda
    de Oliveira, Gislane L. V.
    Tognon, Raquel
    Collassanti, Maria Dulce S.
    Zanichelli, Maria Aparecida
    Hamerschlak, Nelson
    de Souza, Ana Maria
    Covas, Dimas Tadeu
    Kashima, Simone
    de Castro, Fabiola Attie
    ACTA HAEMATOLOGICA, 2015, 133 (04) : 354 - 364
  • [37] Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
    Kantarjian, Hagop
    Shah, Neil P.
    Hochhaus, Andreas
    Cortes, Jorge
    Shah, Sandip
    Ayala, Manuel
    Moiraghi, Beatriz
    Shen, Zhixiang
    Mayer, Jiri
    Pasquini, Ricardo
    Nakamae, Hirohisa
    Huguet, Francoise
    Boque, Concepcion
    Chuah, Charles
    Bleickardt, Eric
    Bradley-Garelik, M. Brigid
    Zhu, Chao
    Szatrowski, Ted
    Shapiro, David
    Baccarani, Michele
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (24) : 2260 - 2270
  • [38] CAY10683 and imatinib have synergistic effects in overcoming imatinib resistance via HDAC2 inhibition in chronic myeloid leukemia
    Zhang, Tianzhuo
    Wei, Danna
    Lu, Tingting
    Ma, Dan
    Yu, Kunlin
    Fang, Qin
    Zhang, Zhaoyuan
    Wang, Weili
    Wang, Jishi
    RSC ADVANCES, 2020, 10 (02) : 828 - 844
  • [39] Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib
    Chuah, Charles
    Melo, Junia V.
    ONCOTARGETS AND THERAPY, 2009, 2 : 83 - 94
  • [40] Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance
    Camgoz, Aylin
    Gencer, Emel Basak
    Ural, Ali Ugur
    Baran, Yusuf
    LEUKEMIA & LYMPHOMA, 2013, 54 (06) : 1279 - 1287
12345